Kintegral Advisory LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 32.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,497 shares of the company's stock after selling 1,716 shares during the period. Kintegral Advisory LLC's holdings in Cardinal Health were worth $482,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Cyrus J. Lawrence LLC purchased a new position in Cardinal Health during the fourth quarter valued at $26,000. Tompkins Financial Corp boosted its stake in shares of Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares during the period. Promus Capital LLC purchased a new stake in Cardinal Health in the 4th quarter valued at about $30,000. Bellwether Advisors LLC purchased a new stake in Cardinal Health in the 4th quarter valued at about $32,000. Finally, Lee Danner & Bass Inc. purchased a new stake in Cardinal Health in the 4th quarter valued at about $35,000. 87.17% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
CAH has been the subject of several recent research reports. Wells Fargo & Company upgraded shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their price target for the company from $136.00 to $179.00 in a report on Tuesday, June 3rd. Evercore ISI restated an "outperform" rating and issued a $180.00 price target (up previously from $175.00) on shares of Cardinal Health in a report on Thursday, June 12th. Robert W. Baird boosted their price target on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Mizuho boosted their price target on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday, March 31st. Finally, Citigroup restated a "neutral" rating and issued a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus price target of $157.43.
Check Out Our Latest Stock Report on Cardinal Health
Cardinal Health Trading Down 1.9%
CAH stock traded down $3.20 during trading on Tuesday, reaching $164.43. 2,066,889 shares of the stock were exchanged, compared to its average volume of 2,244,021. The business has a 50 day moving average price of $156.66 and a 200-day moving average price of $137.98. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $168.44. The firm has a market capitalization of $39.25 billion, a price-to-earnings ratio of 25.65, a P/E/G ratio of 1.66 and a beta of 0.68.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. Cardinal Health's quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.08 earnings per share. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a $0.5107 dividend. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.24%. Cardinal Health's dividend payout ratio is 31.83%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.